Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 11 - The Untold Story

Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026

Gilead Sciences Inc (NASDAQ:GILD) on Thursday reported adjusted earnings of $2.47 per share, beating the consensus of $2.13.

Benzinga · Oct 31, 2025

Alarm in India after children contract HIV from contaminated blood

Authorities order sweeping audit of blood banks after public outrage

The Independent UK · Oct 31, 2025

Deaf man wrongfully told he had HIV after hospital fails to provide interpreter

IN FULL

The Independent UK · Oct 30, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Lack of BSL interpreter left me fearing I had HIV, says man as app launched

Richard MacQueen shared his story as an app is launched which aims to connect people with interpreters more easily.

Evening Standard · Oct 30, 2025

Lack of interpreter left deaf man fearing he ‘had HIV and could die’

When Richard MacQueen’s test results came back, there was no interpreter to pass them on

The Independent UK · Oct 30, 2025

GSK boosted by cancer and HIV drugs as Emma Walmsley bows out

Shares in the company rose on Wednesday morning as a result, lifting to their highest level for more than a year.

Evening Standard · Oct 29, 2025

Thousands who unknowingly had HIV and hepatitis identified though new tests

The initiative was rolled out across emergency departments in areas with the highest rates of HIV.

Evening Standard · Oct 29, 2025

Read news from The Economist, FT, and more,
with one subscription

HIV prevention jab approved for use in England and Wales – here’s how it works

The first ever injectable drug that can prevent HIV has been approved for use in England and Wales.

The Conversation · Oct 23, 2025

PHOTO ESSAY: Lesotho faces deep uncertainty after tariff threats and foreign aid cuts

In the wake of massive U.S. cuts in foreign aid as well as tariffs imposed by President Donald Trump’s administration, the small southern African country of Lesotho faces deep uncertainty over its fight to end the HIV epidemic and its economy.

The Independent UK · Oct 21, 2025

Stark plea for UK not to cut aid funding to fight biggest killer infections

Polling finds two-thirds of Brits believe the UK should increase or maintain its support for the Global Fund in battle against HIV, TB and Malaria

The Independent UK · Oct 20, 2025

UNAids is set to close in 2026 – four years early. Are experts right to be alarmed?

The move to shut the agency comes as aid budgets are being slashed, leading to fears that global progress on HIV may be reversed

The Guardian - UK · Oct 20, 2025

‘London could 100% compete with Cannes’: Aids charity UK gala debut honours Tracey Emin

AmfAR, set up by Elizabeth Taylor, is known for hosting lavish parties and raising huge sums for HIV and Aids research

The Guardian - UK · Oct 18, 2025

UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment

The U.K.’s National Institute for Health and Care Excellence (NICE) is recommending a treatment from a firm jointly owned by GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE) and Shionogi Inc.

Benzinga · Oct 17, 2025

England and Wales to get long-lasting HIV prevention jab for first time

The drug, known as cabotegravir, must be administered every two months.

Euronews · Oct 17, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · Oct 17, 2025

‘Gamechanging’ HIV prevention jab to be approved for England and Wales

Long-acting injection offers alternative to daily pills taken to protect against the virus

The Independent UK · Oct 17, 2025

‘Game-changing’ HIV jab to be offered in England and Wales

The rollout is expected to begin around three months after Nice publishes its final guidance later this year

Evening Standard · Oct 17, 2025

‘Game-changing’ HIV prevention jab to be offered in England and Wales

The National Institute for Health and Care Excellence recommended the injection for people at risk of HIV who are unable to take oral PrEP.

The Independent UK · Oct 16, 2025

South Africa welcomes $115M US bridge plan to sustain its HIV programs for 6 months

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs until the end of March

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation · Oct 16, 2025

HIV rates are highest in the American South, despite effective treatments – a clash between culture and public health

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in 2023. This is despite growing availability of a highly effective HIV prevention medication that has made it possible to live a long, healthy life with this once fatal…

The Independent UK · Oct 16, 2025

Fear and worry in Lesotho: Photos show those affected as US aid cuts affect care for HIV patients

For the 2.3 million residents of Lesotho, the announcement of massive cuts to the U.S. aid that sustained much of the small African nation’s health care system came as a shock. The country long had one of the world’s highest HIV infection rates but recently made notable progress and hit…

The Independent UK · Oct 16, 2025

US aid cuts deal a massive blow for the small African nation of Lesotho: Takeaways from AP's report

In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and worry over its HIV-positive residents

The Independent UK · Oct 16, 2025

Trump’s aid cuts reverse decades of HIV progress in tiny African nation

With the single stroke of Trump’s pen, much of a system credited with saving hundreds of thousands of lives was dismantled

The Independent UK · Oct 14, 2025

South Africa's health minister hails new HIV prevention jab but warns of limited supply

South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool against the disease

Bored Panda · Oct 9, 2025

Doctor Reveals Disturbing Toilet Paper Danger In Public Bathrooms After Furious Dad’s Video Goes Viral

The practice exposes others to bloodborne pathogens such as hepatitis and HIV.

The Independent UK · Oct 9, 2025

What is bluetoothing? Dangerous new drug trend that may be driving a global HIV surge

Method has become popular among drug users in poverty-stricken areas of Africa and Pacific areas

1 … 10 11 12 13

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the National Institute for Health and Care Excellence

30 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.